| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496350A Improved process for preparing pure ondansetron hydrochloride dihydrate |
| 05/12/2004 | CN1496349A (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane, compositions and uses thereof |
| 05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |
| 05/12/2004 | CN1496271A Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 05/12/2004 | CN1496267A Preventives for microbial infections |
| 05/12/2004 | CN1496264A 4-fluoro-N-indan-2-Y1 benzamide and its use as pharmaceutical |
| 05/12/2004 | CN1496259A New use |
| 05/12/2004 | CN1496256A Combination of EPOTHILONE analogs and chemotherapeutic agents for treatment of proliferative diseases |
| 05/12/2004 | CN1496255A Inhibition of NF-KB by triterpene compositions |
| 05/12/2004 | CN1495262A Non-splicing variant of gp 350/220 |
| 05/12/2004 | CN1495198A Analogs of glucagon-like peptide-1 |
| 05/12/2004 | CN1495169A Pyridine-3-carboxylic acid derivative |
| 05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
| 05/12/2004 | CN1494885A Granulation method of raw medicine component preparation |
| 05/12/2004 | CN1494837A Xinjian tobacco. health-care cigarette |
| 05/12/2004 | CN1149280C Replacement therapy for dental caries |
| 05/12/2004 | CN1149215C Phenyl Yanthine derivatives |
| 05/12/2004 | CN1149212C Peperidine derivatives as reuptake inhibitors |
| 05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
| 05/12/2004 | CN1149193C Substituted tricyclic compound |
| 05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
| 05/12/2004 | CN1149190C Nitric oxide synthase inhibitors |
| 05/12/2004 | CN1149090C Medicine bolus for treating Yin-deficiency constipation |
| 05/12/2004 | CN1149082C Di-and trivalent small molecule selecting protein inhibitors |
| 05/12/2004 | CN1149078C Treatment of chronic inflammatory disorders of gastrointestinal tract |
| 05/12/2004 | CN1149077C Rapidly disintegrable solid preparation |
| 05/12/2004 | CN1149021C Liquid oral compositions comprising a calcium compound and an acidulant |
| 05/12/2004 | CN1149018C Method and equipment for destructive distillation of haw kernel to extract juice |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734301 2,3,4,5-Tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds |
| 05/11/2004 | US6734289 Gastrokines and derived peptides including inhibitors |
| 05/11/2004 | US6734212 Methods and compositions for treating or preventing bacterial infection |
| 05/11/2004 | US6734188 Composition for treatment of constipation and irritable bowel syndrome |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6734181 Gastric acid secretory inhibition activity, gastric mucous membrane protection activity; treatment of ulcers and helicobacter pylori infecions |
| 05/11/2004 | US6734176 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
| 05/11/2004 | US6734170 Cellular uptake of bioactive agents |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733801 Method of using fermented glycine max (L) extract for enhancing natural killer cell activity |
| 05/11/2004 | CA2156481C 5-ht2 receptor antagonist compositions useful in treating venous conditions |
| 05/11/2004 | CA2101779C Defoaming composition |
| 05/06/2004 | WO2004038408A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 05/06/2004 | WO2004038407A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) |
| 05/06/2004 | WO2004038406A2 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42) |
| 05/06/2004 | WO2004038405A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) |
| 05/06/2004 | WO2004037829A1 Novel benzoxazole or oxazolopyridine compounds, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037822A1 7-phenyl pyrazolopyridine compounds |
| 05/06/2004 | WO2004037817A1 N-oxide compounds |
| 05/06/2004 | WO2004037280A1 Angiogenesis inducer |
| 05/06/2004 | WO2004037273A1 Therapeutic and/or preventive agent for dyschezia |
| 05/06/2004 | WO2004037256A1 Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist |
| 05/06/2004 | WO2004037255A1 Use of tenatoprazole for the treatment of gastroesophageal reflux |
| 05/06/2004 | WO2004037253A1 Amorphous form of esomeprazole salts |
| 05/06/2004 | WO2004037187A2 Metal-containing materials, compositions and methods |
| 05/06/2004 | WO2004037184A2 Methods for the treatment of skin disorders |
| 05/06/2004 | WO2004037161A2 Cyclic prodrugs of pmea one of its analogues |
| 05/06/2004 | WO2004018451A8 Pyridazinone-derivatives as pde4 inhibitors |
| 05/06/2004 | WO2004013629A3 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 05/06/2004 | WO2004013119B1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 05/06/2004 | WO2004011423A3 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 05/06/2004 | WO2004009585A3 Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors |
| 05/06/2004 | WO2004004750A3 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 05/06/2004 | WO2004000042A3 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 05/06/2004 | WO2003105893A3 Probiotic therapies using lactobacillus reuteri |
| 05/06/2004 | WO2003105838A3 MODULATION OF ACTIVATION OF GLUCOCORTICOID RECEPTORS beta-BREAKDOWN PRODUCTS OF GLUCOCORTICOIDS |
| 05/06/2004 | WO2003099318A3 Pancreas-specific proteins |
| 05/06/2004 | WO2003092580A3 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 05/06/2004 | WO2003088923A3 Methods of treating ileus |
| 05/06/2004 | WO2003051365A9 Use of compounds of the benzamide family as immunosuppressant |
| 05/06/2004 | WO2003046008A9 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| 05/06/2004 | WO2003045316A9 Polynucleotide therapy |
| 05/06/2004 | WO2003016351B1 N - cam related compounds modulating cell groth |
| 05/06/2004 | WO2003005971A8 Tetracycline compounds having target therapeutic activities |
| 05/06/2004 | WO2003004467A3 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 05/06/2004 | WO2002102800A9 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors |
| 05/06/2004 | WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 05/06/2004 | WO2002074251A9 Monoclonal antibody therapy for pancreas cancer |
| 05/06/2004 | WO2001072754A9 Alkylated imidazopyridine derivatives |
| 05/06/2004 | US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain. |
| 05/06/2004 | US20040087796 Substituted carbazoles as inhibitors of spla2 |
| 05/06/2004 | US20040087792 Tryptase-inhibitors |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087654 Nitric oxide synthase inhibitor phosphate salt |
| 05/06/2004 | US20040087640 Administering by mouth; cyclooxygenase inhibitor; controlling particle size |
| 05/06/2004 | US20040087637 Antiserotonine agents; central nervous system disorders |
| 05/06/2004 | US20040087630 Combinations |
| 05/06/2004 | US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases |
| 05/06/2004 | US20040087622 Gastrointestinal disorders; side effect reduction |
| 05/06/2004 | US20040087604 Immunosuppressants; antiallergens |
| 05/06/2004 | US20040087594 Diaminothiazoles having antiproliferative activity |
| 05/06/2004 | US20040087590 Novel biphenyl and biphenyl-like cannabinoids |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087575 Therapeutic chromone compounds |
| 05/06/2004 | US20040087574 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040087538 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 05/06/2004 | US20040087518 Rehydration composition |
| 05/06/2004 | US20040087510 Cardiovascular diseases and disorders; sustained delivery of nitric oxide |